Skip to main content

Table 1 Characteristics of the patients at entry

From: LDL-cholesterol lowering effect of a new dietary supplement: an open label, controlled, randomized, cross-over clinical trial in patients with mild-to-moderate hypercholesterolemia

 

all patients (19 patients)

sequence N-A (10 patients)

sequence A-N (9 patients)

Gender (F/M)

13/6

7/3

6/3

Age (years)

54.7 ± 9.3 (36–70)

56.2 ± 9.6 (37–69)

53.1 ± 9.2 (36–70)

Height (cm)

168 ± 11

169 ± 9

167 ± 13

Weight (Kg)

86 ± 24

84 ± 24

87 ± 26

Body Mass Index (Kg/m2)

30.3 ± 8.2

29.4 ± 8.2

31.3 ± 8.6

  1. Data are expressed as mean ± SD (min-max range)